drugset / Trial / NCT00022295
Phenoxodiol in Treating Patients With Refractory Solid Tumors
Treatment
Summary
RATIONALE: Phenoxodiol may stop the growth of tumor cells by blocking the enzymes necessary for cancer cell growth. PURPOSE: Phase I trial to study the effectiveness of phenoxodiol in treating patients who have refractory solid tumors.
Timeline
- Start
- 2001-08
- Primary completion
- —
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | idronoxil | Small molecule | — | Intravenous |